genXone S.A. operates in the biotechnology industry in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It offers nucleic acid sequencing services based on nanopore sequencing technology. The company develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. is based in Suchy Las, Poland.
Metrics to compare | GX1 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGX1PeersSector | |
---|---|---|---|---|
P/E Ratio | −5.2x | −6.2x | −0.5x | |
PEG Ratio | 7.37 | −0.02 | 0.00 | |
Price/Book | 1.9x | 2.9x | 2.6x | |
Price / LTM Sales | 10.4x | 22.1x | 3.3x | |
Upside (Analyst Target) | - | 48.1% | 43.5% | |
Fair Value Upside | Unlock | 6.4% | 6.8% | Unlock |